3WZ-29696-70788
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 347 / FL
- Registered
- 2021-12-04
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-12-02
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-12-04
Registered in v-safe
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-16
- 2021-12-23
- 2022-01-01
-
2022-01-06
Survey response — day 35, dose 3MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sniffles, sore throat and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-01-13
- 2022-03-03
- 2022-06-02
- 2022-12-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | No |
| 2 | 2021-04-27 | Pfizer-BioNTech | No |
| 3 | 2021-12-02 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 35, dose 3
Symptoms: Sniffles, sore throat and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release